Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study

Condition:   Thyroid Cancer
Intervention:   Drug: Sorafenib
Sponsor:   Instituto Nacional de Cancerologia, Columbia
Recruiting - verified August 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/2b60BwR
via IFTTT